Emerging strategies on in silico drug development against COVID-19: challenges and opportunities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging strategies on in silico drug development against COVID-19: challenges and opportunities

Published:2020-12 Issue: Volume:155 Page:105522
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Yadav Manisha,Dhagat Swasti,Eswari J. Satya^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference184 articles.

1. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;MBio,2018

2. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs;Anand;Science,2003

3. The proximal origin of SARS-CoV-2;Andersen;Nat. Med.,2020

4. Discovery and development of safe-in-man broad-spectrum antiviral agents;Andersen;Int. J. Infect. Dis.,2020

5. Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro;Bacha;Biochemistry,2004

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery;Genes & Diseases;2023-07

2. SARS-CoV-2 main protease targeting potent fluorescent inhibitors: Repurposing thioxanthones;Turkish Journal of Chemistry;2023-01-01

3. Metalloproteome of human-infective RNA viruses: a study towards understanding the role of metal ions in virology;Pathogens and Disease;2023

4. Environmental pollutants and their impact on COVID‐19 spread: Current problem and future resolutions;Carbon Neutralization;2023-01

5. Molecular Docking and the Pharmacokinetic Properties of the Anti-Viral Compounds Towards SARS-CoV- An In-silico Approach;International Journal of Pharmaceutical Research And Allied Sciences;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3